Search
-
Vaccines Wavre 2019 Ir Event Slides 26 Sep 2019 Final
Media
https://www.gsk.com/media/8115/vaccines-wavre-2019-ir-event-slides-26-sep-2019-final.pdf
First published: 01 June 2022
-
Randd Day Transcript Full
Media
https://www.gsk.com/media/8195/randd-day-transcript-full.pdf
First published: 06 June 2022
-
Gsk Investor Event
Media
https://www.gsk.com/media/8210/gsk-investor-event.pdf
First published: 06 June 2022
-
Script Word Version 070621 Pdf
Media
https://www.gsk.com/media/8017/script-word-version-070621-pdf.pdf
First published: 01 June 2022
-
GSK and Intercell form strategic alliance to develop and commercialise innovative needle-free patch-based vaccines
Media
GlaxoSmithKline Biologicals SA (GSK) and Intercell today announced an agreement to form a strategic alliance to accelerate the development.
https://www.gsk.com/en-gb/media/press-releases/gsk-and-intercell-form-strategic-alliance-to-develop-and-commercialise-innovative-needle-free-patch-based-vaccines/
First published: 10 December 2009
-
Jpmorgan Healthcare Conference 2015
Media
https://www.gsk.com/media/8226/jpmorgan-healthcare-conference-2015.pdf
First published: 06 June 2022
-
R And D Event Full Presentation
Media
https://www.gsk.com/media/8194/r-and-d-event-full-presentation.pdf
First published: 06 June 2022
-
GSK and CureVac to restructure collaboration into new licensing agreement
Media
GSK acquires full rights to develop, manufacture and commercialise globally mRNA candidate vaccines for influenza and COVID-19.
https://www.gsk.com/en-gb/media/press-releases/gsk-and-curevac-to-restructure-collaboration-into-new-licensing-agreement/
First published: 03 July 2024
-
Abbas Hussain Investor Event Presentation
Media
https://www.gsk.com/media/8216/abbas-hussain-investor-event-presentation.pdf
First published: 06 June 2022
-
Emma Walmsley Key Priorities
Media
https://www.gsk.com/media/8161/emma-walmsley-key-priorities.pdf
First published: 06 June 2022
